Navigation Links
Former Official Confesses He Had Sold Steroids to Leading Baseball Players

A former official of the Mets, a leading baseball team of New York, has pleaded guilty yesterday in federal court in San Francisco to distributing// performance-enhancing drugs to dozens of former and current Major League Baseball players for a decade.

Kirk Radomski, 37, who had worked as a clubhouse assistant for the Mets from 1985-95, admitted to selling banned drugs, including anabolic steroids, amphetamines and human growth hormone, from 1995 through 2005, according to a plea agreement filed in the United States District Court in the Northern District of California.

He also pleaded guilty to laundering the money from the drug transactions. The two felony charges carry sentences of up to 25 years in prison and a maximum of 500,000 dollars in fines. None of his clients were named in the plea agreement.

Allan Huber 'Bud' Selig, a senior official of the Major League Baseball, the virtual apex body of professional baseball in the US, told a Congressional committee that the steroid problem in baseball had been blown out of proportion.

'Do we have a major problem? No,' he said. Radomski said in his statement, 'I had personal contact with some of my baseball drug clients, but consulted and conducted drug transactions with others over the telephone and mail.'

When his home was searched in December 2005 federal agents seized 'thousands of doses of numerous types of anabolic steroids in both pill and injectable form - human growth hormone, insulin growth factor, clomiphene, a fertility drug that can be used as a masking agent, steroid Clenbuterol, to name some of them.

Federal agents also seized shipping records, financial records, correspondences and contact lists that detailed the distribution of drugs to major league baseball players.

Major League Baseball issued a statement saying it supported 'the efforts of the U.S. attorney’s office in combating the illegal use of performance-enhancing sub
'"/>




Page: 1 2

Related medicine news :

1. Former smokers can be protected with vitamin A derivative
2. Reliable Help For Smokers From Nicotine Patches and Former Smokers
3. Former IMO President Shows Interest In Winning General Election
4. Former FDA Commissioner Accused in Criminal Case
5. Justice To Former Male Nurse In sex Discrimination Case
6. Residents Of Former Industrial Towns In UK Most likely To Become Obese
7. Former Malaysian Prime Minister Suffers Heart Attack
8. Fact Sheet on Polonium-210 - The Substance That Killed Former Russian Spy
9. Former Chilean Dictator Hospitalised After Heart Attack
10. Former Chilean Dictator Recovering
11. Italian Who Met Former KBG Spy is Arrested
Post Your Comments:
(Date:9/15/2014)... (PRWEB) September 15, 2014 Insurers ... initiatives that bring providers on board as partners ... satisfaction. When bundled payment programs are designed properly ... incentives, incentivize hospitals to work collaboratively with providers, ... tally. On Sept. 24, the Atlantic Information Services ...
(Date:9/15/2014)... New Jersey, Sept 9, 2014 – New Jersey ... firm of Ricci Tyrrell Johnson & Grey, PLLC, has ... No. 8,774,911 from the United States Patent and Trademark ... locator instrument is invented by Dr. Lee M. Buono ... in minimally-invasive spine surgery. , Precise pedicle location is ...
(Date:9/15/2014)... September 15, 2014 Recently, Top10BestSEOHosting.com ... announced that GreenGeeks ( http://www.greengeeks.com/cgi-bin/affiliates/clickthru.cgi?id=seohosts ), IX Web ... suppliers in 2014. , “These companies have outperformed ... customer support, so that we call them the ... people can get the best web hosting to ...
(Date:9/14/2014)... 14, 2014 When active, the protein ... several human cancers including pancreatic, prostate, lung, colon and ... available. A study published today in the journal Nature ... these Ral proteins: "When you want to keep an ... shut. We took another approach – we put a ...
(Date:9/14/2014)... -- Getting enough sleep each night may mean you,re less likely ... study suggests. The study included more than 3,700 people in ... of seven years. Those who slept less than six hours ... to have extended absences from work due to illness, the investigators ... work due to sickness were those who slept between seven and ...
Breaking Medicine News(10 mins):Health News:Sept. 24 Webinar to Profile Geisinger Health System, BCBS of North Carolina’s Successful Bundled-Payment Programs 2Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 2Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 3Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 4Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 5Health News:Nature: New drug blocks gene driving cancer growth 2Health News:Nature: New drug blocks gene driving cancer growth 3Health News:A Good Night's Sleep May Mean a Good Day's Work 2
... 57 million Americans currently living with "pre-diabetes" could benefit from ... a new study published in this month,s American Journal ... Weight Watchers group program, overweight or obese adults who attended ... lost weight, but also significantly reduced fasting glucose and insulin ...
... Georgia Institute of Technology has received a $100,000 Grand ... Foundation. The grant will support an innovative global health ... in Georgia Tech,s School of Mechanical Engineering, titled "Complement-based ... grants announced by the Gates Foundation in the fourth ...
... successful testing of a sensor that can instantly tell whether ... by emergency room doctors to determine whether a patient has ... diabetics do not take enough insulin. Someday the technology may ... determine whether they need more insulin. A report on the ...
... Through ... and rare diseases are possible before they ever manifest. The future of medicine starts ... (PRWEB) ... world’s first predictive medicine company, is working with healthcare providers to PREDICT, PREVENT, and ...
... ... ... -- IT-Lifeline, the Northwest’s foremost provider of disaster recovery and business continuity solutions, and ... have entered into a joint marketing agreement to provide a suite of Disaster Recovery ...
... fingerroot inhibited production of carcinogenic compounds , THURSDAY, May ... to your burgers before tossing them on the grill ... of the meat, but they can also cut the ... beef. , Scientists at Kansas State University (KSU) found ...
Cached Medicine News:Health News:New study finds attending Weight Watchers meetings helps reduce the risk for type 2 diabetes 2Health News:Georgia Tech awarded Gates Foundation grant for innovative global health research 2Health News:Existence Genetics is Pioneering the Field of Predictive Medicine - Nexus Technologies Critical in Understanding and Preventing Deadly Disease 2Health News:Existence Genetics is Pioneering the Field of Predictive Medicine - Nexus Technologies Critical in Understanding and Preventing Deadly Disease 3Health News:IT-Lifeline, Inc and OptiStor Technologies, Inc. Enter Joint Marketing Agreement 2Health News:IT-Lifeline, Inc and OptiStor Technologies, Inc. Enter Joint Marketing Agreement 3Health News:Some Spices Cut Cancer Risk That Comes With Grilled Burgers 2
(Date:9/14/2014)... 2014  Abbott announced today positive one-year clinical ... randomized, controlled trial comparing the safety and effectiveness ... market-leading metallic XIENCE family of DES.  The trial, ... included 501 people with coronary artery disease (CAD), ... results were featured at a late-breaking session at ...
(Date:9/12/2014)... Colorado eye care provider Vision Care Specialists announced expansion ... high quality eye care services. Photo - http://photos.prnewswire.com/prnh/20140912/145684 ... locations in Aurora , Lakewood ... days a week. Hours are Monday, Tuesday, Thursday and Friday 7:45 ... Saturday 7:45 AM to 2:30 PM. The downtown Denver ...
(Date:9/12/2014)...   Synthetic Biologics, Inc. (NYSE MKT: ... and drug programs targeting specific pathogens that cause ... U.S. Food and Drug Administration (FDA) has granted ... monoclonal antibody (mAb) combination for the treatment of ... the U.S., Orphan Drug Designation provides a variety ...
Breaking Medicine Technology:ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 2ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 3ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 4ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 5Colorado Eye Care: Vision Care Specialists Expands Hours, adds Optometrists to Denver Locations 2Colorado Eye Care: Vision Care Specialists Expands Hours, adds Optometrists to Denver Locations 3Synthetic Biologics Receives Orphan Drug Designation for SYN-005 Treatment for Whooping Cough (Pertussis) 2Synthetic Biologics Receives Orphan Drug Designation for SYN-005 Treatment for Whooping Cough (Pertussis) 3
... and Efficacy Data Reported ... Enrollment Advancing Ahead of Schedule, SOUTH SAN FRANCISCO, ... ) today presented an update of interim,data from the ... product,candidate, voreloxin (formerly SNS-595), in platinum-resistant ovarian,cancer patients at ...
... Results Confirm Previously Demonstrated Survival Advantages of Tarceva in ... This Difficult-to-Treat Disease ... - ABSTRACT No: 4507, ... Tarceva (erlotinib) and chemotherapy significantly,improves the time patients with metastatic pancreatic cancer ...
Cached Medicine Technology:Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 2Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 3Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 4Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 5Patients with Pancreatic Cancer Can Benefit From Avastin(R) Plus Tarceva(R) 2Patients with Pancreatic Cancer Can Benefit From Avastin(R) Plus Tarceva(R) 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: